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Measles vaccine effectiveness and risk factors for measles
in Dhaka, Bangladesh
Syed M. Akramuzzaman,1 Felicity T. Cutts,2 Md J. Hossain,3 Obaidullah K. Wahedi,4 Nazmun Nahar,5
Darul Islam,6 Narayan C. Shaha,7 & Dilip Mahalanabis8
Objective To evaluate vaccine effectiveness and to assess risk factors for measles in Dhaka, Bangladesh.
Method A case-control study, involving 198 cases with 783 age-matched neighbourhood controls and 120 measles cases with
365 age-matched hospital controls, was conducted in 1995–96 in three large hospitals in Dhaka.
Findings Measles vaccine effectiveness was estimated at 80% (95% confidence interval (CI) = 60–90%) using neighbourhood
controls; very similar results were obtained using hospital controls. Visits to a health facility 7–21 days before onset of any symptoms
were associated with increased risk of measles compared with neighbourhood (adjusted odds ratio (OR) = 7.0, 95% CI = 4.2–11.6)
or hospital (adjusted OR = 1.7, 95% CI = 1.01–2.8) controls. Cases were more likely than controls to come from a household where
more than one child lived (adjusted OR = 1.6, 95% CI = 1.1–2.5 versus neighbourhood controls; adjusted OR = 1.8, 95%
CI = 1.02–3.0 versus hospital controls).
Conclusions To improve measles control in urban Dhaka missed immunization opportunities must be reduced in all health care
facilities by following WHO guidelines. For measles elimination, more than one dose of vaccine would be required.
Keywords Measles vaccine/therapeutic use; Measles/etiology; Cross infection; Immunization; Risk factors; Socioeconomic factors;
Case-control studies; Odds ratio; Bangladesh (source: MeSH, NLM ).
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Introduction
WHO estimates that almost 1 million measles-related deaths
occur each year (1), the majority (85%) in Africa and Asia. In
Bangladesh, measles remains a major cause of childhood
morbidity and mortality. Population-based surveillance of
121 018 residents of a poor periurban area in Dhaka reported
a measles incidence of 57 per 1000 per year among under-5-
year-olds in 2001 (A. Brooks, personal communication,
2001). Among children under 5 years of age attending a large
hospital in urban Dhaka in 2000, 5% reported a recent
history of measles (A.S.G. Faruque, personal communica-
tion, 2000). A nationwide verbal autopsy study among a
representative sample of under-5-year-olds who died be-
tween 1992 and 1996 reported that 6% of these deaths were
due to acute measles and 15% to post-measles diarrhoea or
pneumonia (2).
As measles vaccine coverage increases, it becomes more
important to identify risk factors for measles and target
supplementary immunization strategies at high-risk groups. It
is also important to provide high-quality immunization
services. Vaccine effectiveness is expected to be at least 85%
whenmeasles vaccine is administered at 9months of age (3–6),
but cold chain and other programme failures have reduced
effectiveness in rural (7, 8) and urban (9, 10) areas in developing
countries.
Studies in West Africa (11–13) and the USA (14–18)
have shown that nosocomial infection of measles is common
among children (19). The importance of control of nosocomial
transmission of measles in the global context was demon-
strated by an outbreak ofmeasles in aDutch hospital following
introduction of measles by an infant from Indonesia (20). The
WHO Expanded Programme on Immunization advocates a
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policy of immunizing children at every contact with health
facilities, but the extent to which this is implemented varies
widely.
We conducted a study in Dhaka, Bangladesh in 1995–96
to evaluate measles vaccine effectiveness and identify risk
factors for measles.
Materials and methods
The matched case–control study, using two sets of controls,
was approved by the ethics committees of the International
Centre for Diarrhoeal Disease Research, Bangladesh
(ICDDR,B) and the London School of Hygiene and Tropical
Medicine. Cases and hospital controls were selected from three
large tertiary care hospitals: ICDDR,B hospital (a specialist
hospital for diarrhoeal diseases), Dhaka Shishu Hospital (the
largest paediatric hospital), and the paediatric department of
DhakaMedical College teaching hospital, which have 300, 300,
and 60 beds, respectively. Physicians and study health workers
asked each mother attending outpatient or inpatient depart-
ments whether her child had had measles in the previous
6 weeks. Children living in urban Dhaka and presenting with a
history of measles-like illness in the previous 6 weeks
(generalized maculopapular rash of53 days’ duration with a
history of fever and cough, coryza or conjunctivitis) were
enrolled as cases (21).
We aimed to select four neighbourhood controls for
each case, by visiting neighbouring households sequentially
until four controls were identified. The controls were matched
within age ranges (5–8, 9–11, 12–23, 24–35, 36–47, 48–59, 60–
83, 84–107 and >108 months) and had no previous history of
measles. We also attempted to recruit four age-matched
controls from the same hospital, who lived at a similar distance
from the hospital as the matched case. Children with
pneumonia and pertussis were excluded because of the
potential for nosocomial transmission. Poliomyelitis, tubercu-
losis, and surgical cases were not eligible as controls because
our preliminarywork suggested that theirmothers’ perceptions
of severity and usefulness of medical care were different from
those for measles.
After obtaining their written informed consent, the
parents of cases and controls were interviewed by health
workers using pre-tested, structured questionnaires. Data
collected included age, sex, socioeconomic status, parental
education, number of children in the household, history of
exposure to measles cases, and distance travelled and time
taken to reach hospitals. Immunization status was recorded
from documents or from the verbal history given by the
parent if no record was available. Respondents were asked
whether the child had been to a health facility during the
3 months prior to enrolment, and if so, when the most recent
visit had occurred and the reason for it. The same
information was then requested for each previous visit,
working backwards.
Laboratory assays were performed at ICDDR,B.
Measles IgM antibody levels were measured using enzyme-
linked immunosorbent assay kits (Enzygnost, Behring Diag-
nostics, Frankfurt, Germany). Each run of IgM assays included
a positive and a negative control. The overall sensitivity of this
test (for immunized and non-immunized subjects) for
detection of measles IgM in measles cases confirmed by
complement fixation test is 97.2% (22).
Data analysis
Data were double entered and validated using Epi Info
software (23). Only measles cases confirmed by measles-
specific IgM were retained in the analysis. All comparisons
between cases and controls were conducted separately for
neighbourhood and hospital controls. Only those children
whose parents said they had received measles vaccine at least
2 weeks before enrolment or onset of prodromal symptoms
were considered to have been vaccinated (24). For health
facility visits, exposure was defined as a visit to a health facility
at least once 7–21 days prior to the onset of the first
symptoms of the episode of illness (fever, cough, difficult
breathing, or diarrhoea) (19, 25, 26) or prior to enrolment of
healthy neighbourhood controls. This corresponded to
attendance at a health facility within the incubation period
of measles.
Conditional logistic regression models (27) were used to
estimate the effect of measles immunization and health facility
visits on the risk of measles, controlling for potential
confounding factors. Inclusion of age in logistic regression
models made little difference to the results, hence we present
data without adjusting for age. We were interested a priori in
exploring interactions between vaccine effectiveness and sex,
and did so by comparing a multivariable model that included
the interaction term with one that excluded it using the
likelihood ratio test (28).
We also examined risk factors for severe measles cases
that had any of the following complications: dehydration, signs
of lower respiratory infection, bloody diarrhoea, meningitis, or
clinical sepsis. To assess whether risk factors for measles
differed in immunized compared with non-immunized
children, we conducted analyses stratified by immunization
status, using only case–control sets of concordant measles
immunization status.
Results
Measles cases were enrolled in each month throughout the
study period, with peaks in recruitment inMay–August. Similar
seasonality of clinically diagnosedmeasles was reported among
a 2% systematic sample of patients attending ICDDR,B during
1995 and 1996 (Fig. 1).
Clinical characteristics of cases and controls
A total of 206 confirmed measles cases were recruited, a
median of 10 days (interquartile range, 6–15 days) after the
onset of rash. The median age was 17 months (range = 5–
118 months). All measles cases had a history of typical
morbiliform rash and fever, 68% had watery diarrhoea, and
38% had lower respiratory infections. For almost half of the
measles cases, parents reported contact with another child with
measles-like rash; this was a householdmeasles case in 33 cases
(16%), but parents could not give a precise date of exposure in
relation to the study case. The median age of hospital controls
was 13 months (range = 6–107 months). The most common
illnesses were acute watery diarrhoea (74%), invasive diarrhoea
(9%), persistent diarrhoea (5%), chronic otitis media (11%),
pyogenic meningitis (3%), upper respiratory tract infection
(6%), thrush (4%), and skin infection (7%). For neighbour-
hood controls, specific symptoms included fever (12%) and
cough (28%), with few reports of diarrhoea or other
symptoms.
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Case–control analysis using neighbourhood controls
Of the 206 measles cases, six were removed from hospital by
their families or consent was withdrawn, and for two cases no
neighbourhood controls could be found. The remaining 198
cases and 783matched neighbourhood controls were retained.
Cases were more likely than controls to be male, non-
immunized, have a less educated or working mother, a
household head other than the father, and more than one child
in the household (Table 1). Household income was slightly
lower among cases than controls (data not shown).
The crude and adjusted odds ratios (OR) for receipt of
measles vaccine were 0.2 (Table 2); vaccine effectiveness was
thus 80% (95% confidence interval (CI) = 60–90%). Among
92 severe measles cases and 364 age-matched controls, vaccine
effectiveness was 90% (95% CI = 70–94%).
A total of 27% of cases had visited a health facility 7–
21 days before prodrome compared with only 6% of
neighbourhood controls. As shown in Table 2, after
controlling for measles immunization, sex, socioeconomic
status, and number of children in the household, the adjusted
OR for a health facility visit was 7.0 (95% CI = 4.2–11.6,
P <0.001). There was no significant interaction of age or sex
in the association between health facility visit and measles.
For the subgroup of severe measles cases, the OR for health
facility attendance in this prodromal period was 8.9 (95%
CI = 3.6–22.0).
Stratification by immunization status showed that health
facility attendance and the presence of more than one child in
the household appeared to be greater risk factors formeasles in
immunized than in non-immunized children. Among the
42 immunized cases with 94 age-matched immunized con-
trols, the OR for health facility attendance was 24.7 (95%
CI = 5.3–114.7, P <0.001) and the OR for more than one
child in the householdwas 4.6 (95%CI = 0.8–24.8,P = 0.07).
Among 156 non-immunized cases and 344 age-matched non-
immunized controls the ORs were 4.1 (95% CI = 2.2–7.8,
P <0.001) and 1.4 (95% CI = 0.5–1.4, P = 0.5), respectively.
Children who had attended a health facility 7–21 days
prior to onset of illness or enrolment were more frequent users
of health facilities in general. Among the 54 cases and
51 controls who visited during the risk period, 41% and 33%,
respectively, also attended over the period 21 days to 3months
before onset. For cases and controls, attendance at health
facilities was associated with younger age (median age,
13 months compared with 22 months), higher level of
education of household head, and higher income, but not
with sex or immunization status (data not shown).
Case–control study using hospital controls
Suitable hospital controls could not be found for 80 cases. The
median age of cases for whom controls could or could not be
found was 14 and 40 months, respectively (P <0.001). There
were no significant differences in socioeconomic character-
istics (data not shown), and the proportion immunized against
measles was virtually identical in cases for which controls could
or could not be found: 21% and 22%, respectively.
Cases and hospital controls were comparable with
respect to the distance of their residence from the hospitals
(5.5 km versus 6.0 km, P = 0.2) and time required to travel to
the hospital (30min versus 40 min, P = 0.8). Cases came from
households with less educated parents, more children
(Table 1), and lower median incomes (data not shown).
Results using hospital controls were broadly similar to
those using neighbourhood controls (Table 2). Vaccine
effectiveness was 80% using measles or severe measles cases.
Health facility attendance was a significant risk factor,
especially among immunized children, although the corre-
sponding ORs were lower than estimated using neighbour-
hood controls.
Discussion
Vaccine effectiveness
This study evaluated measles vaccine effectiveness and risk
factors for measles in a large city with moderately high average
vaccine coverage. Vaccine effectiveness was estimated at 80%,
irrespective of whether hospital or neighbourhood controls
were used. This is within the expected range when measles
vaccine is administered at 9 months of age (3–6). The estimate
of protection by vaccine was slightly higher against severe
measles when neighbourhood controls were used, which is
consistent with reports that when measles occurs in
immunized individuals the illness is less severe (29).
For studies of vaccine effectiveness, cases should ideally
be ascertained in such a way that the likelihood of detecting
them among immunized or non-immunized children is the
same. Cases recruited at hospital may represent families with a
relatively high use of health facilities, including immunization
services. This would tend to bias observed vaccine effective-
ness downwards. On the other hand, we had some evidence
that measles cases were milder in immunized than in non-
immunized children, thus hospital-based recruitment may
have increased the observed vaccine effectiveness.
We confirmed measles serologically, thus avoiding the
potential bias in vaccine effectiveness from non-specific
diagnosis (9). Immunization status was only documented in
17% (7/42) of cases and 29% (107/367) of neighbourhood
controls and thus was prone to misclassification. However, we
did not have adequate statistical power to conduct a statistical
analysis on subgroups of children with or without documented
measles immunization status. If misclassification was non-
differential, this would bias the observed vaccine effectiveness
towards zero. There may, however, have been differential
misclassification since cases had less educated mothers who
might give less accurate information on their child’s
immunization status (9) and are also less likely to take their
children for immunization (30).
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Risk factors
Measles was more common in households with more than one
child. This could reflect an increased risk of exposure to
measles, increased severity of measles (31), or both. The
association between number of children in the household and
measles was somewhat stronger for severe measles cases than
for non-severe measles cases (adjusted OR = 1.8 and 1.4,
respectively, using neighbourhood controls; 3.1 and 1.5,
respectively, using hospital controls), but we lacked the
statistical power to determine whether this difference was
significant.
Our results showed that visiting a health facility 7–
21 days prior to disease onset was a risk factor for measles,
suggesting that nosocomial transmission of measles was
occurring in urban Dhaka. Previous studies had been
conducted during epidemics (11, 18, 32). Our study shows
that even in the absence of a recognized measles outbreak,
there is a risk of transmission at health facilities. Over 90% of
the health facility visits were said to be due to childhood illness;
approximately half were at private practitioner or nongovern-
mental outpatient clinics and only about one-tenth resulted in
hospital admission.
Table 1. Comparison of selected demographic and socioeconomic characteristics in 198 measles cases and 783 age-matched
neighbourhood controls and 120 measles cases and 365 age-matched hospital controls in urban Dhaka, Bangladesh, 1995–96
Characteristic No. of measles No. of neighbourhood No. of measles No. of hospital
cases controls cases controls
Age group (months)
5–8
9–11
12–23
24–35
36–47
48–59
60–83
84–107
>108
33 (17)a
29 (15)
51 (26)
18 (9)
16 (8)
21 (11)
16 (8)
11 (6)
3 (1)
131 (17)
112 (14)
201 (26)
72 (9)
63 (8)
84 (11)
64 (8)
44 (6)
12 (1)
27 (23)
23 (19)
35 (29)
11 (9)
6 (5)
10 (8)
5 (4)
3 (3)
–
91 (25)
79 (22)
112 (31)
34 (9)
11 (3)
17 (5)
15 (4)
6 (2)
–
Sex
Male
Female
118 (60)
80 (40)
401 (51)
382 (49)
72 (60)
48 (40)
193 (53)
172 (47)
Received measles vaccine (verbal report) 42 (21)b 367 (47) 27 (23)b 180 (49)
Household head
Father
Other
180 (91)c
18 (9)
742 (95)
41 (5)
112 (93)
8 (7)
343 (94)
22 (6)
Occupation of household head
Unemployed
Service
Business
Petty business
Skilled labourer
Unskilled labourer
Other
3 (2)
40 (20)
44 (22)
3 (2)
32 (16)
75 (38)
1 (1)
15 (2)
158 (20)
194 (25)
24 (3)
94 (12)
290 (37)
8 (1)
2 (2)
28 (23)
27 (23)
2 (2)
20 (17)
40 (33)
1 (1)
7 (2)
101 (28)
83 (23)
14 (4)
43 (12)
116 (32)
1
Education of household head
No schooling
Schooling
88 (44)
110 (56)
338 (43)
444 (57)
57 (48)c
63 (52)
136 (37)
232 (63)
Mother’s education
No schooling
Schooling
134 (68)d
64 (32)
450 (58)
198 (42)
76 (63)d
44 (37)
178 (49)
187 (51)
Mother’s occupation
Housewife
Other
157 (79)c
41 (21)
669 (85)
114 (15)
96 (80)
24 (20)
307 (84)
57 (16)
No. of rooms in household
1
>1
163 (82)
35 (18)
655 (84)
128 (16)
99 (83)
21 (17)
284 (78)
81 (22)
No. children aged <12 years in household
1
>1
41 (21)
157 (79)
203 (26)
580 (74)
26 (22)c
94 (78)
125 (34)
240 (66)
a Figures in parentheses are percentages.
b P <0.001.
c P <0.05.
d P <0.01.
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Case–control groups
Neighbourhood controls were less likely than cases or
hospital controls to report attendance at health facilities
during the 3 months prior to recruitment. Reported atten-
dance rates among neighbourhood controls aged <5 years
were similar to those in a study on health-care seeking
behaviour in urban slums of Dhaka (33). Since cases were
recruited in hospitals, at least part of the difference in health
facility attendance between cases and neighbourhood controls
may reflect an association with the chance of being
hospitalized once ill, rather than with exposure to measles.
The association with health facility attendance over the study
period was, however, also significant when we compared
cases with hospital controls. For this case–control group,
there was no difference in background health-care seeking
behaviour (as assessed by visits 21 days to 3 months
previously). We therefore consider that the association
represents an increased chance of exposure to measles. The
odds ratio for this group may have been biased towards zero,
since some of the cases of upper respiratory tract infection
and diarrhoea among controls may have been transmitted
nosocomially (34, 35).
Missed vaccination opportunities
The target age range for measles vaccination in Bangladesh is
9 months to 2 years. In this study, 61 cases in this age group
were not immunized; 21 (34%) had visited health facilities
before the incubation period of measles. Since the measles
vaccine had an effectiveness of 80%, measles could have been
prevented in 17 of these 21 cases if the vaccine had been given
during their health facility visits. Severe measles was observed
in 30 non-immunized cases in this age group of whom 6 (20%)
had visited health facilities before the incubation period. Given
the vaccine effectiveness of 90% against severemeasles, five of
these cases could have been prevented if these children had
been immunized during their health facility visits. Opportu-
nities for measles immunization were missed overall for
27 (19%) of 145 non-immunized neighbourhood controls and
36 (47%) of 77 unvaccinated hospital controls in children aged
9 months to 2 years.
Table 2. Results of conditional regression models showing odds ratios (OR) and 95% confidence intervals (CI) for health facility
visits as a risk factor for measles and severe measles, and for measles immunization as a protective factor against measles
and severe measles, adjusted for all covariates for which estimates are provided, urban Dhaka, Bangladesh, 1995–96
Using neighbourhood controls Using hospital controls
Variable Measles Severe measles Measles Severe measles
Crude Adjusted ORa Crude Adjusted ORb Crude Adjusted ORc Crude Adjusted ORd
OR (95% CI) OR 95% CI OR (95% CI) OR (95% CI)
Health care facility visite
Not visited
Visited
1.0f
6.0g
1.0
7.0 (4.2, 11.6)g,h
1.0
7.3g
1.0
8.9 (3.6, 22.0)g
1.0
1.5
1.0
1.7 (1.0, 2.8)i
1.0
1.1
1.0
1.4 (0.6, 3.6)
Sex
Male
Female
1.0
0.7i
1
0.7 (0.5,1.0)
1.0
0.7
1.0
0.8 (0.5, 1.4)
1.0
0.6
1.0
0.7 (0.4, 1.1)
1.0
0.9
1.0
0.9 (0.4, 2.2)
Measles immunization status
Not immunized
Immunized
1.0
0.2g
1.0
0.2 (0.1, 0.4)g
1.0
0.1g
1.0
0.1 (0.06,0.3)g
1.0
0.2g
1.0
0.2 (0.1, 0.4)g
1.0
0.2g
1.0
0.2 (0.07, 0.5)g
Mother’s education
No schooling
Schooling
1.0
0.6j
1.0
0.7 (0.5, 1.1)
1.0
0.5j
1.0
0.6 (0.3, 1.1)
1.0
0.6i
1.0
0.7 (0.4, 1.1)
1.0
0.5
1.0
0.8 (0.3, 2.0)
Mother’s occupation
Housewife
Other
1.0
0.6i
1.0
0.7 (0.4, 1.0)
1.0
0.6
1.0
0.6 (0.3, 1.2)
1.0
0.8
1.0
0.9 (0.5, 1.7)
1.0
1.1
1.0
1.4 (0.5, 4.0)
No. of children in household
One child
More than one child
1.0
1.4
1.0
1.6 (1.1, 2.5)i
1.0
2.2j
1.0
1.8 (0.9, 3.6)
1.0
1.7i
1.0
1.8 (1.0, 3.0)i
1.0
3.3i
1.0
3.1 (1.0, 9.5)i
Household income
< Median
> Median
1.0
0.8
1.0
0.8 (0.5, 1.2)
1.0
0.9
1.0
0.9 (0.5, 1.6)
1.0
0.7
1.0
0.9 (0.5, 1.6)
1.0
0.7
1.0
0.8 (0.3, 2.1)
a OR estimates were based on 198 measles cases and 783 age-matched neighbourhood controls.
b OR estimates were based on 92 severe measles cases and 363 age-matched neighbourhood controls.
c OR estimates were based on 120 measles cases and 365 age-matched hospital controls.
d OR estimates were based on 42 severe measles cases and 125 age-matched hospital controls.
e Health care facility visit: visit to a health care facility for any reason 7–21 days before the onset of cough, fever, difficult respiration or diarrhoea, or before recruitment (for
controls without any symptom).
f Referent.
g P < 0.001.
h Figures in parentheses are 95% confidence intervals.
i P < 0.05.
j P < 0.01.
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Measles remains a disease of public health importance in
Dhaka, with substantial numbers of hospital admissions and
increased susceptibility to pneumonia and invasive diarrhoea
for 6–8 weeks after measles onset (36). Although average
immunization coverage in Dhaka is reported to be moderately
high (65%), in slum areas it is only 52% (37).
Approximately 40% of the measles cases in our study
were in the target age group for measles immunization, and the
majority was not immunized. The continued occurrence of
measles in Dhaka reflects programmatic weaknesses in
addition to vaccine failure. Measles control can be improved
by targeting pockets of low coverage through better
coordination among the different agencies providing immu-
nization services, motivating parents regarding the need for
measles immunization, and implementing WHO recommen-
dations for using all opportunities to immunize children (19).
Nonetheless, with a primary vaccine failure rate of 20%, to
eliminate measles as a public health problem, a two-dose
schedule is likely to be needed, either through routine services
or periodic supplementary campaigns.
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Re´sume´
Efficacite´ du vaccin antirougeoleux et facteurs de risque pour la rougeole a` Dhaka (Bangladesh)
Objectif Evaluer l’efficacite´ du vaccin et les facteurs de risque pour
la rougeole a` Dhaka (Bangladesh).
Me´thodes Une e´tude cas-te´moins portant sur 198 cas et
783 te´moins apparie´s sur l’aˆge et recrute´s parmi les voisins des
cas, et d’autre part sur 120 cas et 365 te´moins apparie´s sur l’aˆge et
recrute´s parmi des personnes hospitalise´es, a e´te´ re´alise´e en 1995-
1996 dans trois grands hoˆpitaux de Dhaka.
Re´sultats L’efficacite´ du vaccin antirougeoleux a e´te´ estime´e a`
80 % (intervalle de confiance a` 95 % (IC) : 60-90 %) en prenant
comme te´moins des voisins des cas ; des re´sultats tout a` fait
similaires ont e´te´ obtenus avec les te´moins hospitalise´s. On a
observe´ une augmentation du risque de rougeole chez les sujets
s’e´tant rendus dans un e´tablissement de soins 7 a` 21 jours avant
le de´but des symptoˆmes par rapport aux te´moins du voisinage
(odds ratio (OR) ajuste´ = 7,0 ; IC 95 % : 4,2-11,6) ou aux
te´moins hospitalise´s (OR ajuste´ = 1,7 ; IC 95 % : 1,01-2,8). Les
cas provenaient, avec une plus grande probabilite´ que les
te´moins, de me´nages comptant plus d’un enfant (OR ajuste´
= 1,6 ; IC 95 % : 1,1-2,5 par rapport aux te´moins du voisinage ;
OR ajuste´ = 1,8 ; IC 95 % : 1,02-3,0 par rapport aux te´moins
hospitalise´s).
Conclusion Pour ame´liorer la lutte contre la rougeole en zone
urbaine de Dhaka, il faudra re´duire les occasions manque´es de
vaccination dans tous les e´tablissements de soins de sante´ en
suivant les directives de l’OMS. Pour e´liminer la rougeole, il faudrait
utiliser plus d’une dose de vaccin.
Resumen
Eficacia de la vacuna antisarampionosa y factores de riesgo de sarampio´n en Dacca (Bangladesh)
Objetivo Evaluar la eficacia de la vacuna y los factores de riesgo
de sarampio´n en Dacca, Bangladesh.
Me´todos En 1995–1996 se realizo´ en tres grandes hospitales de
Dacca un estudio de casos y controles que abarco´ 198 casos con
783 testigos del vecindario emparejados por edades, ası´ como
otros 120 casos de sarampio´n emparejados tambie´n por edades
con 365 testigos de un entorno hospitalario.
Resultados Comparando con los controles del vecindario, se
estimo´ que la vacuna antisarampionosa tenı´a una eficacia del 80%
(intervalo de confianza (IC) del 95% = 60%–90%); los resultados
fueron muy parecidos al utilizar los controles del hospital. Las
visitas a un establecimiento de salud 7–21 dı´as antes de la
aparicio´n de cualquier sı´ntoma se asociaron a un mayor riesgo de
sarampio´n en comparacio´n con los controles del vecindario (razo´n
de posibilidades (OR) ajustada = 7,0, IC95% = 4,2–11,6) o del
hospital (OR ajustada = 1,7, IC95% = 1,01–2,8). Los casos
tenı´an ma´s probabilidades que los controles de provenir de un
hogar donde vivı´a ma´s de un nin˜o (OR ajustada = 1,6, IC95%
= 1,1–2,5 frente a los controles del vecindario; OR ajustada
= 1,8, IC95% = 1,02–3,0 frente a los controles del hospital).
Conclusio´n A fin de mejorar la lucha antisarampionosa en las
zonas urbanas de Dacca, hay que aprovechar mejor las
oportunidades de inmunizacio´n en todos los establecimientos
de asistencia sanitaria, siguiendo las directrices de la OMS. Para
lograr eliminar el sarampio´n se requerira´ ma´s de una dosis de la
vacuna.
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